The Enterprise Value as of December 2025 (TTM) for Day One Biopharmaceuticals, Inc. (DAWN) is 815.93M

According to Day One Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 815.93M. This represents a change of 2.84% compared to the average of 793.42M of the last 4 quarters.

Day One Biopharmaceuticals, Inc. (DAWN) Historical Enterprise Value (quarterly & annually)

How has DAWN Enterprise Value performed in the past?

The mean historical Enterprise Value of Day One Biopharmaceuticals, Inc. over the last ten years is 1.15B. The current 815.93M Enterprise Value has changed 6.97% with respect to the historical average. Over the past ten years (40 quarters), DAWN's Enterprise Value was at its highest in in the December 2022 quarter at 1.50B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Day One Biopharmaceuticals, Inc. (DAWN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Day One Biopharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Day One Biopharmaceuticals, Inc. (DAWN) Average Enterprise Value

How has DAWN Enterprise Value performed in the past?

The current Enterprise Value of Day One Biopharmaceuticals, Inc. (DAWN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Day One Biopharmaceuticals, Inc. (DAWN) Enterprise Value vs. Peers

How is DAWN’s Enterprise Value compared to its peers?

Day One Biopharmaceuticals, Inc.’s Enterprise Value is less than Geron Corporation (854.51M), greater than Valneva SE (687.21M), less than Arvinas, Inc. (819.49M), greater than Replimune Group, Inc. (804.93M), less than Tyra Biosciences, Inc. (1.09B), less than Rezolute, Inc. (891.81M), less than ArriVent BioPharma, Inc. Common Stock (892.49M), greater than Astria Therapeutics, Inc. (677.40M), less than Erasca, Inc. (888.32M), greater than Vir Biotechnology, Inc. (737.27M),

Build a custom stock screener for Day One Biopharmaceuticals, Inc. (DAWN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Day One Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Day One Biopharmaceuticals, Inc. (DAWN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Day One Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.